In chronic lymphocytic leukemia cells, which express high levels of CD44, a humanized monoclonal antibody specific for CD44 (RG7356) was found to be cytotoxic to leukemia B cells without affecting the viability of normal B cells. This evidence concerns the gene CD44 and leukemia.